Company Filing History:
2 out of 22 
1 out of 321 
Years Active: 2018-2021
Title: Na-Rae Shin: Innovator in Asthma Treatment
Introduction
Na-Rae Shin is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for asthma. With a total of 2 patents, his work focuses on innovative compositions that aim to alleviate the symptoms of this chronic condition.
Latest Patents
One of Na-Rae Shin's latest patents is a pharmaceutical composition containing a monoacetyldiacylglycerol compound as an active ingredient for preventing or treating asthma. This invention relates to both a pharmaceutical composition and a functional health food composition designed to combat asthma. The monoacetyldiacylglycerol compound has been shown to inhibit the expression of IL-4 in EL-4 cells, which are mouse T cell lymphoma cells. It also reduces airway hypersensitivity in an asthma-induced animal model and inhibits the infiltration of inflammatory cells into the bronchial tube. Furthermore, the compounds inhibit the generation of IgE in serum and bronchoalveolar lavage fluid, demonstrating an excellent effect in inhibiting the expression of Th2 cytokines (IL-4, IL-5, and IL-13) in the lung. This innovation overcomes the side effects associated with currently used therapeutic agents for asthma, exhibits no toxicity, and provides a superior therapeutic effect, making it a valuable composition for preventing, treating, and alleviating asthma.
Career Highlights
Na-Rae Shin has worked with notable organizations such as Enzychem Lifesciences Corporation and the Korea Research Institute of Bioscience and Biotechnology. His experience in these institutions has contributed to his expertise in developing effective treatments for respiratory conditions.
Collaborations
Some of his coworkers include Sei-Ryang Oh and Kyung Seop Ahn. Their collaborative efforts have likely played a role in advancing the research and development of innovative solutions in the field of asthma treatment.
Conclusion
Na-Rae Shin's contributions to asthma treatment through his innovative patents highlight his dedication to improving health outcomes for individuals suffering from this condition. His work continues to pave the way for advancements in pharmaceutical compositions aimed at alleviating asthma symptoms.